Pharma & Healthcare
Global Covid-19 Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 344208
- Pages: 128
- Figures: 129
- Views: 5
In 2024, the global market size of Covid-19 Vaccine was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Covid-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Vaccine.
The Covid-19 Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Covid-19 Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Covid-19 Vaccine in global and regional level.
Chapter 3: Detailed analysis of Covid-19 Vaccine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Vaccine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Covid-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Vaccine.
The Covid-19 Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Covid-19 Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Covid-19 Vaccine in global and regional level.
Chapter 3: Detailed analysis of Covid-19 Vaccine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Vaccine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Covid-19 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Covid-19 Vaccine Market Size Estimates and Forecasts
2.2 Covid-19 Vaccine Market Size by Region: 2024 Versus 2031
2.2.1 Global Covid-19 Vaccine Revenue by Region: 2020-2025
2.2.2 Global Covid-19 Vaccine Revenue Forecast by Region (2026-2031)
2.2.3 Global Covid-19 Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Covid-19 Vaccine Revenue by Type (2020-2031)
3.1.2 Global Covid-19 Vaccine Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Covid-19 Vaccine Revenue by Application (2020-2031)
3.2.2 Global Covid-19 Vaccine Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 DNA of Covid-19 Vaccine Revenue Market Share by Application
3.3.2 Non-replicating Viral Vector of Covid-19 Vaccine Revenue Market Share by Application
3.3.3 Protein Subunit of Covid-19 Vaccine Revenue Market Share by Application
3.3.4 RNA of Covid-19 Vaccine Revenue Market Share by Application
3.3.5 Others of Covid-19 Vaccine Revenue Market Share by Application
4 Global Covid-19 Vaccine by Company
4.1 Global Covid-19 Vaccine Revenue by Company (2020-2025)
4.2 Global Covid-19 Vaccine Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Covid-19 Vaccine Companies around the World: Ranking by Revenue
4.3.2 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Covid-19 Vaccine Companies Headquarters & Product Type
4.4.1 Global Covid-19 Vaccine Companies Headquarters
4.4.2 Date of International Companies Enter into Covid-19 Vaccine Market
4.4.3 Global Covid-19 Vaccine Companies Product & Service
4.4.4 DNA Revenue Market Share of Covid-19 Vaccine by Company
4.4.5 Non-replicating Viral Vector Revenue Market Share of Covid-19 Vaccine by Company
4.4.6 Protein Subunit Revenue Market Share of Covid-19 Vaccine by Company
4.4.7 RNA Revenue Market Share of Covid-19 Vaccine by Company
4.4.8 Others Revenue Market Share of Covid-19 Vaccine by Company
4.5 Global Covid-19 Vaccine Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Moderna
5.1.1 Moderna Corporation Information
5.1.2 Moderna Description, Business Overview
5.1.3 Moderna Covid-19 Vaccine Products Offered
5.1.4 Moderna Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.1.5 Moderna Covid-19 Vaccine Revenue by Product in 2024
5.1.6 Moderna Covid-19 Vaccine Revenue by Application in 2024
5.1.7 Moderna Covid-19 Vaccine Revenue by Geographic Area in 2024
5.1.8 Moderna Recent Developments
5.2 CanSino Biologicals
5.2.1 CanSino Biologicals Corporation Information
5.2.2 CanSino Biologicals Description, Business Overview
5.2.3 CanSino Biologicals Covid-19 Vaccine Products Offered
5.2.4 CanSino Biologicals Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.2.5 CanSino Biologicals Covid-19 Vaccine Revenue by Product in 2024
5.2.6 CanSino Biologicals Covid-19 Vaccine Revenue by Application in 2024
5.2.7 CanSino Biologicals Covid-19 Vaccine Revenue by Geographic Area in 2024
5.2.8 CanSino Biologicals Recent Developments
5.3 Inovio Pharmaceuticals
5.3.1 Inovio Pharmaceuticals Corporation Information
5.3.2 Inovio Pharmaceuticals Description, Business Overview
5.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Products Offered
5.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.3.5 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Product in 2024
5.3.6 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Application in 2024
5.3.7 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Geographic Area in 2024
5.3.8 Inovio Pharmaceuticals Recent Developments
5.4 Shenzhen Geno-Immune Medical Institute
5.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
5.4.2 Shenzhen Geno-Immune Medical Institute Description, Business Overview
5.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Products Offered
5.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.4.5 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Product in 2024
5.4.6 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Application in 2024
5.4.7 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Geographic Area in 2024
5.4.8 Shenzhen Geno-Immune Medical Institute Recent Developments
5.5 GlaxoSmithKine
5.5.1 GlaxoSmithKine Corporation Information
5.5.2 GlaxoSmithKine Description, Business Overview
5.5.3 GlaxoSmithKine Covid-19 Vaccine Products Offered
5.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.5.5 GlaxoSmithKine Covid-19 Vaccine Revenue by Product in 2024
5.5.6 GlaxoSmithKine Covid-19 Vaccine Revenue by Application in 2024
5.5.7 GlaxoSmithKine Covid-19 Vaccine Revenue by Geographic Area in 2024
5.5.8 GlaxoSmithKine Recent Developments
5.6 Pfizer
5.6.1 Pfizer Corporation Information
5.6.2 Pfizer Description, Business Overview
5.6.3 Pfizer Covid-19 Vaccine Products Offered
5.6.4 Pfizer Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.6.5 Pfizer Covid-19 Vaccine Revenue by Product in 2024
5.6.6 Pfizer Covid-19 Vaccine Revenue by Application in 2024
5.6.7 Pfizer Covid-19 Vaccine Revenue by Geographic Area in 2024
5.6.8 Pfizer Recent Developments
5.7 Johnson＆Johnson
5.7.1 Johnson＆Johnson Corporation Information
5.7.2 Johnson＆Johnson Description, Business Overview
5.7.3 Johnson＆Johnson Covid-19 Vaccine Products Offered
5.7.4 Johnson＆Johnson Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.7.5 Johnson＆Johnson Covid-19 Vaccine Revenue by Product in 2024
5.7.6 Johnson＆Johnson Covid-19 Vaccine Revenue by Application in 2024
5.7.7 Johnson＆Johnson Covid-19 Vaccine Revenue by Geographic Area in 2024
5.7.8 Johnson＆Johnson Recent Developments
5.8 Heat Biologics
5.8.1 Heat Biologics Corporation Information
5.8.2 Heat Biologics Description, Business Overview
5.8.3 Heat Biologics Covid-19 Vaccine Products Offered
5.8.4 Heat Biologics Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.8.5 Heat Biologics Covid-19 Vaccine Revenue by Product in 2024
5.8.6 Heat Biologics Covid-19 Vaccine Revenue by Application in 2024
5.8.7 Heat Biologics Covid-19 Vaccine Revenue by Geographic Area in 2024
5.8.8 Heat Biologics Recent Developments
5.9 Sanofi
5.9.1 Sanofi Corporation Information
5.9.2 Sanofi Description, Business Overview
5.9.3 Sanofi Covid-19 Vaccine Products Offered
5.9.4 Sanofi Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.9.5 Sanofi Covid-19 Vaccine Revenue by Product in 2024
5.9.6 Sanofi Covid-19 Vaccine Revenue by Application in 2024
5.9.7 Sanofi Covid-19 Vaccine Revenue by Geographic Area in 2024
5.9.8 Sanofi Recent Developments
6 North America
6.1 North America Covid-19 Vaccine Market Size YoY Growth 2020-2031
6.2 North America Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
6.3 North America Covid-19 Vaccine Revenue by Type (2020-2025)
6.4 North America Covid-19 Vaccine Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Covid-19 Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Covid-19 Vaccine Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Covid-19 Vaccine Revenue by Type (2020-2025)
7.4 Asia-Pacific Covid-19 Vaccine Revenue by Application (2020-2025)
8 Europe
8.1 Europe Covid-19 Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
8.3 Europe Covid-19 Vaccine Revenue by Type (2020-2025)
8.4 Europe Covid-19 Vaccine Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Covid-19 Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
9.3 Latin America Covid-19 Vaccine Revenue by Type (2020-2025)
9.4 Latin America Covid-19 Vaccine Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Covid-19 Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Covid-19 Vaccine Revenue by Type (2020-2025)
10.4 Middle East and Africa Covid-19 Vaccine Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Covid-19 Vaccine Supply Chain Analysis
11.2 Covid-19 Vaccine Key Raw Materials and Upstream Suppliers
11.3 Covid-19 Vaccine Clients Analysis
11.4 Covid-19 Vaccine Sales Channel and Sales Model Analysis
11.4.1 Covid-19 Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Covid-19 Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Covid-19 Vaccine Distributors
12 Covid-19 Vaccine Market Dynamics
12.1 Covid-19 Vaccine Industry Trends
12.2 Covid-19 Vaccine Market Drivers
12.3 Covid-19 Vaccine Market Challenges
12.4 Covid-19 Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Covid-19 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Covid-19 Vaccine Market Size Estimates and Forecasts
2.2 Covid-19 Vaccine Market Size by Region: 2024 Versus 2031
2.2.1 Global Covid-19 Vaccine Revenue by Region: 2020-2025
2.2.2 Global Covid-19 Vaccine Revenue Forecast by Region (2026-2031)
2.2.3 Global Covid-19 Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Covid-19 Vaccine Revenue by Type (2020-2031)
3.1.2 Global Covid-19 Vaccine Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Covid-19 Vaccine Revenue by Application (2020-2031)
3.2.2 Global Covid-19 Vaccine Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 DNA of Covid-19 Vaccine Revenue Market Share by Application
3.3.2 Non-replicating Viral Vector of Covid-19 Vaccine Revenue Market Share by Application
3.3.3 Protein Subunit of Covid-19 Vaccine Revenue Market Share by Application
3.3.4 RNA of Covid-19 Vaccine Revenue Market Share by Application
3.3.5 Others of Covid-19 Vaccine Revenue Market Share by Application
4 Global Covid-19 Vaccine by Company
4.1 Global Covid-19 Vaccine Revenue by Company (2020-2025)
4.2 Global Covid-19 Vaccine Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Covid-19 Vaccine Companies around the World: Ranking by Revenue
4.3.2 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Covid-19 Vaccine Companies Headquarters & Product Type
4.4.1 Global Covid-19 Vaccine Companies Headquarters
4.4.2 Date of International Companies Enter into Covid-19 Vaccine Market
4.4.3 Global Covid-19 Vaccine Companies Product & Service
4.4.4 DNA Revenue Market Share of Covid-19 Vaccine by Company
4.4.5 Non-replicating Viral Vector Revenue Market Share of Covid-19 Vaccine by Company
4.4.6 Protein Subunit Revenue Market Share of Covid-19 Vaccine by Company
4.4.7 RNA Revenue Market Share of Covid-19 Vaccine by Company
4.4.8 Others Revenue Market Share of Covid-19 Vaccine by Company
4.5 Global Covid-19 Vaccine Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Moderna
5.1.1 Moderna Corporation Information
5.1.2 Moderna Description, Business Overview
5.1.3 Moderna Covid-19 Vaccine Products Offered
5.1.4 Moderna Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.1.5 Moderna Covid-19 Vaccine Revenue by Product in 2024
5.1.6 Moderna Covid-19 Vaccine Revenue by Application in 2024
5.1.7 Moderna Covid-19 Vaccine Revenue by Geographic Area in 2024
5.1.8 Moderna Recent Developments
5.2 CanSino Biologicals
5.2.1 CanSino Biologicals Corporation Information
5.2.2 CanSino Biologicals Description, Business Overview
5.2.3 CanSino Biologicals Covid-19 Vaccine Products Offered
5.2.4 CanSino Biologicals Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.2.5 CanSino Biologicals Covid-19 Vaccine Revenue by Product in 2024
5.2.6 CanSino Biologicals Covid-19 Vaccine Revenue by Application in 2024
5.2.7 CanSino Biologicals Covid-19 Vaccine Revenue by Geographic Area in 2024
5.2.8 CanSino Biologicals Recent Developments
5.3 Inovio Pharmaceuticals
5.3.1 Inovio Pharmaceuticals Corporation Information
5.3.2 Inovio Pharmaceuticals Description, Business Overview
5.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Products Offered
5.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.3.5 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Product in 2024
5.3.6 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Application in 2024
5.3.7 Inovio Pharmaceuticals Covid-19 Vaccine Revenue by Geographic Area in 2024
5.3.8 Inovio Pharmaceuticals Recent Developments
5.4 Shenzhen Geno-Immune Medical Institute
5.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
5.4.2 Shenzhen Geno-Immune Medical Institute Description, Business Overview
5.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Products Offered
5.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.4.5 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Product in 2024
5.4.6 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Application in 2024
5.4.7 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue by Geographic Area in 2024
5.4.8 Shenzhen Geno-Immune Medical Institute Recent Developments
5.5 GlaxoSmithKine
5.5.1 GlaxoSmithKine Corporation Information
5.5.2 GlaxoSmithKine Description, Business Overview
5.5.3 GlaxoSmithKine Covid-19 Vaccine Products Offered
5.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.5.5 GlaxoSmithKine Covid-19 Vaccine Revenue by Product in 2024
5.5.6 GlaxoSmithKine Covid-19 Vaccine Revenue by Application in 2024
5.5.7 GlaxoSmithKine Covid-19 Vaccine Revenue by Geographic Area in 2024
5.5.8 GlaxoSmithKine Recent Developments
5.6 Pfizer
5.6.1 Pfizer Corporation Information
5.6.2 Pfizer Description, Business Overview
5.6.3 Pfizer Covid-19 Vaccine Products Offered
5.6.4 Pfizer Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.6.5 Pfizer Covid-19 Vaccine Revenue by Product in 2024
5.6.6 Pfizer Covid-19 Vaccine Revenue by Application in 2024
5.6.7 Pfizer Covid-19 Vaccine Revenue by Geographic Area in 2024
5.6.8 Pfizer Recent Developments
5.7 Johnson＆Johnson
5.7.1 Johnson＆Johnson Corporation Information
5.7.2 Johnson＆Johnson Description, Business Overview
5.7.3 Johnson＆Johnson Covid-19 Vaccine Products Offered
5.7.4 Johnson＆Johnson Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.7.5 Johnson＆Johnson Covid-19 Vaccine Revenue by Product in 2024
5.7.6 Johnson＆Johnson Covid-19 Vaccine Revenue by Application in 2024
5.7.7 Johnson＆Johnson Covid-19 Vaccine Revenue by Geographic Area in 2024
5.7.8 Johnson＆Johnson Recent Developments
5.8 Heat Biologics
5.8.1 Heat Biologics Corporation Information
5.8.2 Heat Biologics Description, Business Overview
5.8.3 Heat Biologics Covid-19 Vaccine Products Offered
5.8.4 Heat Biologics Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.8.5 Heat Biologics Covid-19 Vaccine Revenue by Product in 2024
5.8.6 Heat Biologics Covid-19 Vaccine Revenue by Application in 2024
5.8.7 Heat Biologics Covid-19 Vaccine Revenue by Geographic Area in 2024
5.8.8 Heat Biologics Recent Developments
5.9 Sanofi
5.9.1 Sanofi Corporation Information
5.9.2 Sanofi Description, Business Overview
5.9.3 Sanofi Covid-19 Vaccine Products Offered
5.9.4 Sanofi Covid-19 Vaccine Revenue and Gross Margin (2020-2025)
5.9.5 Sanofi Covid-19 Vaccine Revenue by Product in 2024
5.9.6 Sanofi Covid-19 Vaccine Revenue by Application in 2024
5.9.7 Sanofi Covid-19 Vaccine Revenue by Geographic Area in 2024
5.9.8 Sanofi Recent Developments
6 North America
6.1 North America Covid-19 Vaccine Market Size YoY Growth 2020-2031
6.2 North America Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
6.3 North America Covid-19 Vaccine Revenue by Type (2020-2025)
6.4 North America Covid-19 Vaccine Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Covid-19 Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Covid-19 Vaccine Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Covid-19 Vaccine Revenue by Type (2020-2025)
7.4 Asia-Pacific Covid-19 Vaccine Revenue by Application (2020-2025)
8 Europe
8.1 Europe Covid-19 Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
8.3 Europe Covid-19 Vaccine Revenue by Type (2020-2025)
8.4 Europe Covid-19 Vaccine Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Covid-19 Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
9.3 Latin America Covid-19 Vaccine Revenue by Type (2020-2025)
9.4 Latin America Covid-19 Vaccine Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Covid-19 Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Covid-19 Vaccine Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Covid-19 Vaccine Revenue by Type (2020-2025)
10.4 Middle East and Africa Covid-19 Vaccine Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Covid-19 Vaccine Supply Chain Analysis
11.2 Covid-19 Vaccine Key Raw Materials and Upstream Suppliers
11.3 Covid-19 Vaccine Clients Analysis
11.4 Covid-19 Vaccine Sales Channel and Sales Model Analysis
11.4.1 Covid-19 Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Covid-19 Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Covid-19 Vaccine Distributors
12 Covid-19 Vaccine Market Dynamics
12.1 Covid-19 Vaccine Industry Trends
12.2 Covid-19 Vaccine Market Drivers
12.3 Covid-19 Vaccine Market Challenges
12.4 Covid-19 Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Covid-19 Vaccine Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Covid-19 Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Covid-19 Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Covid-19 Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Covid-19 Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Covid-19 Vaccine Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 11. Covid-19 Vaccine Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Covid-19 Vaccine Players by Revenue (US$ Million) in 2024
Table 13. Global Covid-19 Vaccine Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Covid-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2024)
Table 15. Global Covid-19 Vaccine Companies Headquarters
Table 16. Date of International Companies Enter into Covid-19 Vaccine Market
Table 17. Global Covid-19 Vaccine Companies Product & Service
Table 18. Global Covid-19 Vaccine Mergers & Acquisitions, Expansion Plans
Table 19. Moderna Corporation Information
Table 20. Moderna Description and Business Overview
Table 21. Moderna Covid-19 Vaccine Product
Table 22. Moderna Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Moderna Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 24. Moderna Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 25. Moderna Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 26. Moderna Recent Developments
Table 27. CanSino Biologicals Corporation Information
Table 28. CanSino Biologicals Description and Business Overview
Table 29. CanSino Biologicals Covid-19 Vaccine Product
Table 30. CanSino Biologicals Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. CanSino Biologicals Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 32. CanSino Biologicals Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 33. CanSino Biologicals Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 34. CanSino Biologicals Recent Developments
Table 35. Inovio Pharmaceuticals Corporation Information
Table 36. Inovio Pharmaceuticals Description and Business Overview
Table 37. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 38. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Inovio Pharmaceuticals Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 40. Inovio Pharmaceuticals Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 41. Inovio Pharmaceuticals Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 42. Inovio Pharmaceuticals Recent Developments
Table 43. Shenzhen Geno-Immune Medical Institute Corporation Information
Table 44. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 45. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 46. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Shenzhen Geno-Immune Medical Institute Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 48. Shenzhen Geno-Immune Medical Institute Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 49. Shenzhen Geno-Immune Medical Institute Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 50. Shenzhen Geno-Immune Medical Institute Recent Developments
Table 51. GlaxoSmithKine Corporation Information
Table 52. GlaxoSmithKine Description and Business Overview
Table 53. GlaxoSmithKine Covid-19 Vaccine Product
Table 54. GlaxoSmithKine Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. GlaxoSmithKine Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 56. GlaxoSmithKine Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 57. GlaxoSmithKine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 58. GlaxoSmithKine Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Covid-19 Vaccine Product
Table 62. Pfizer Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Pfizer Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 64. Pfizer Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 65. Pfizer Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 66. Pfizer Recent Developments
Table 67. Johnson＆Johnson Corporation Information
Table 68. Johnson＆Johnson Description and Business Overview
Table 69. Johnson＆Johnson Covid-19 Vaccine Product
Table 70. Johnson＆Johnson Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Johnson＆Johnson Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 72. Johnson＆Johnson Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 73. Johnson＆Johnson Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 74. Johnson＆Johnson Recent Developments
Table 75. Heat Biologics Corporation Information
Table 76. Heat Biologics Description and Business Overview
Table 77. Heat Biologics Covid-19 Vaccine Product
Table 78. Heat Biologics Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Heat Biologics Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 80. Heat Biologics Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 81. Heat Biologics Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 82. Heat Biologics Recent Developments
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Covid-19 Vaccine Product
Table 86. Sanofi Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Sanofi Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 88. Sanofi Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 89. Sanofi Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 90. Sanofi Recent Developments
Table 91. North America Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 92. North America Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 93. North America Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 94. North America Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 95. Asia-Pacific Covid-19 Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 96. Asia-Pacific Covid-19 Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 97. Asia-Pacific Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 98. Asia-Pacific Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 99. Europe Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 100. Europe Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 101. Europe Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 102. Europe Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 103. Latin America Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 104. Latin America Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 105. Latin America Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 106. Latin America Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 107. Middle East and Africa Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 108. Middle East and Africa Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 109. Middle East and Africa Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 110. Middle East and Africa Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 111. Covid-19 Vaccine Key Raw Materials, Industry Status and Trend
Table 112. Covid-19 Vaccine Key Raw Materials and Upstream Suppliers
Table 113. Covid-19 Vaccine Clients Status and Trend
Table 114. Covid-19 Vaccine Typical Clients
Table 115. Covid-19 Vaccine Distributors
Table 116. Covid-19 Vaccine Market Trends
Table 117. Covid-19 Vaccine Market Drivers
Table 118. Covid-19 Vaccine Market Challenges
Table 119. Covid-19 Vaccine Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Vaccine Product Picture
Figure 2. Global Covid-19 Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Covid-19 Vaccine Revenue Market Share by Type in 2024 & 2031
Figure 4. DNA Product Picture
Figure 5. Non-replicating Viral Vector Product Picture
Figure 6. Protein Subunit Product Picture
Figure 7. RNA Product Picture
Figure 8. Others Product Picture
Figure 9. Global Covid-19 Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Covid-19 Vaccine Revenue Market Share by Application in 2024 & 2031
Figure 11. Adults
Figure 12. Children
Figure 13. Covid-19 Vaccine Report Years Considered
Figure 14. Global Covid-19 Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Covid-19 Vaccine Market Size (2020-2031) & (US$ Million)
Figure 16. Global Covid-19 Vaccine Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Covid-19 Vaccine Revenue Market Share by Region (2020-2031)
Figure 18. Global Covid-19 Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Covid-19 Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 20. DNA of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 21. Non-replicating Viral Vector of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 22. Protein Subunit of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 23. RNA of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Others of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Covid-19 Vaccine Revenue Share by Company (2024)
Figure 26. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. DNA Revenue Proportion by Company in 2024
Figure 28. Non-replicating Viral Vector Revenue Proportion by Company in 2024
Figure 29. Protein Subunit Revenue Proportion by Company in 2024
Figure 30. RNA Revenue Proportion by Company in 2024
Figure 31. Others Revenue Proportion by Company in 2024
Figure 32. North America Covid-19 Vaccine Revenue 2020-2031 (US$ Million)
Figure 33. North America Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 34. North America Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Covid-19 Vaccine Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 39. Europe Covid-19 Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Covid-19 Vaccine Revenue Market Share by Country (2020-2031)
Figure 41. Europe Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 42. Europe Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Covid-19 Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Covid-19 Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Covid-19 Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 51. Covid-19 Vaccine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Covid-19 Vaccine Raw Materials by Region in 2024
Figure 53. Covid-19 Vaccine Distribution Channels
Figure 54. Global Covid-19 Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Covid-19 Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Covid-19 Vaccine Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Covid-19 Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Covid-19 Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Covid-19 Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Covid-19 Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Covid-19 Vaccine Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 11. Covid-19 Vaccine Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Covid-19 Vaccine Players by Revenue (US$ Million) in 2024
Table 13. Global Covid-19 Vaccine Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Covid-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2024)
Table 15. Global Covid-19 Vaccine Companies Headquarters
Table 16. Date of International Companies Enter into Covid-19 Vaccine Market
Table 17. Global Covid-19 Vaccine Companies Product & Service
Table 18. Global Covid-19 Vaccine Mergers & Acquisitions, Expansion Plans
Table 19. Moderna Corporation Information
Table 20. Moderna Description and Business Overview
Table 21. Moderna Covid-19 Vaccine Product
Table 22. Moderna Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Moderna Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 24. Moderna Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 25. Moderna Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 26. Moderna Recent Developments
Table 27. CanSino Biologicals Corporation Information
Table 28. CanSino Biologicals Description and Business Overview
Table 29. CanSino Biologicals Covid-19 Vaccine Product
Table 30. CanSino Biologicals Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. CanSino Biologicals Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 32. CanSino Biologicals Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 33. CanSino Biologicals Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 34. CanSino Biologicals Recent Developments
Table 35. Inovio Pharmaceuticals Corporation Information
Table 36. Inovio Pharmaceuticals Description and Business Overview
Table 37. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 38. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Inovio Pharmaceuticals Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 40. Inovio Pharmaceuticals Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 41. Inovio Pharmaceuticals Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 42. Inovio Pharmaceuticals Recent Developments
Table 43. Shenzhen Geno-Immune Medical Institute Corporation Information
Table 44. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 45. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 46. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Shenzhen Geno-Immune Medical Institute Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 48. Shenzhen Geno-Immune Medical Institute Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 49. Shenzhen Geno-Immune Medical Institute Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 50. Shenzhen Geno-Immune Medical Institute Recent Developments
Table 51. GlaxoSmithKine Corporation Information
Table 52. GlaxoSmithKine Description and Business Overview
Table 53. GlaxoSmithKine Covid-19 Vaccine Product
Table 54. GlaxoSmithKine Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. GlaxoSmithKine Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 56. GlaxoSmithKine Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 57. GlaxoSmithKine Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 58. GlaxoSmithKine Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Covid-19 Vaccine Product
Table 62. Pfizer Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Pfizer Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 64. Pfizer Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 65. Pfizer Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 66. Pfizer Recent Developments
Table 67. Johnson＆Johnson Corporation Information
Table 68. Johnson＆Johnson Description and Business Overview
Table 69. Johnson＆Johnson Covid-19 Vaccine Product
Table 70. Johnson＆Johnson Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Johnson＆Johnson Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 72. Johnson＆Johnson Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 73. Johnson＆Johnson Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 74. Johnson＆Johnson Recent Developments
Table 75. Heat Biologics Corporation Information
Table 76. Heat Biologics Description and Business Overview
Table 77. Heat Biologics Covid-19 Vaccine Product
Table 78. Heat Biologics Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Heat Biologics Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 80. Heat Biologics Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 81. Heat Biologics Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 82. Heat Biologics Recent Developments
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Covid-19 Vaccine Product
Table 86. Sanofi Covid-19 Vaccine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Sanofi Revenue Proportion of Covid-19 Vaccine by Product in 2024
Table 88. Sanofi Revenue Proportion of Covid-19 Vaccine by Application in 2024
Table 89. Sanofi Revenue Proportion of Covid-19 Vaccine by Geographic Area in 2024
Table 90. Sanofi Recent Developments
Table 91. North America Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 92. North America Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 93. North America Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 94. North America Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 95. Asia-Pacific Covid-19 Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 96. Asia-Pacific Covid-19 Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 97. Asia-Pacific Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 98. Asia-Pacific Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 99. Europe Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 100. Europe Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 101. Europe Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 102. Europe Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 103. Latin America Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 104. Latin America Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 105. Latin America Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 106. Latin America Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 107. Middle East and Africa Covid-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 108. Middle East and Africa Covid-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 109. Middle East and Africa Covid-19 Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 110. Middle East and Africa Covid-19 Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 111. Covid-19 Vaccine Key Raw Materials, Industry Status and Trend
Table 112. Covid-19 Vaccine Key Raw Materials and Upstream Suppliers
Table 113. Covid-19 Vaccine Clients Status and Trend
Table 114. Covid-19 Vaccine Typical Clients
Table 115. Covid-19 Vaccine Distributors
Table 116. Covid-19 Vaccine Market Trends
Table 117. Covid-19 Vaccine Market Drivers
Table 118. Covid-19 Vaccine Market Challenges
Table 119. Covid-19 Vaccine Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Vaccine Product Picture
Figure 2. Global Covid-19 Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Covid-19 Vaccine Revenue Market Share by Type in 2024 & 2031
Figure 4. DNA Product Picture
Figure 5. Non-replicating Viral Vector Product Picture
Figure 6. Protein Subunit Product Picture
Figure 7. RNA Product Picture
Figure 8. Others Product Picture
Figure 9. Global Covid-19 Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Covid-19 Vaccine Revenue Market Share by Application in 2024 & 2031
Figure 11. Adults
Figure 12. Children
Figure 13. Covid-19 Vaccine Report Years Considered
Figure 14. Global Covid-19 Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Covid-19 Vaccine Market Size (2020-2031) & (US$ Million)
Figure 16. Global Covid-19 Vaccine Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Covid-19 Vaccine Revenue Market Share by Region (2020-2031)
Figure 18. Global Covid-19 Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Covid-19 Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 20. DNA of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 21. Non-replicating Viral Vector of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 22. Protein Subunit of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 23. RNA of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Others of Covid-19 Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Covid-19 Vaccine Revenue Share by Company (2024)
Figure 26. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. DNA Revenue Proportion by Company in 2024
Figure 28. Non-replicating Viral Vector Revenue Proportion by Company in 2024
Figure 29. Protein Subunit Revenue Proportion by Company in 2024
Figure 30. RNA Revenue Proportion by Company in 2024
Figure 31. Others Revenue Proportion by Company in 2024
Figure 32. North America Covid-19 Vaccine Revenue 2020-2031 (US$ Million)
Figure 33. North America Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 34. North America Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Covid-19 Vaccine Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 39. Europe Covid-19 Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Covid-19 Vaccine Revenue Market Share by Country (2020-2031)
Figure 41. Europe Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 42. Europe Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Covid-19 Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Covid-19 Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Covid-19 Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Figure 51. Covid-19 Vaccine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Covid-19 Vaccine Raw Materials by Region in 2024
Figure 53. Covid-19 Vaccine Distribution Channels
Figure 54. Global Covid-19 Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Covid-19 Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232